News
Important Only
Stocks
PNC Financial Services Group Inc reports results for the quarter ended March 31 - Earnings Summary
PNC Financial Services Group Inc PNC.N reported quarterly adjusted earnings of $3.51 per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $3.36. The mean expectation of twenty analysts for the quarter was for earnings of $3.38 per shar...Reuters
Tue, Apr 15
Stocks
Albertsons Companies Inc reports results for the quarter ended February 28 - Earnings Summary
Albertsons Companies Inc ACI.N reported quarterly adjusted earnings of 46 cents per share for the quarter ended February 28, lower than the same quarter last year, when the company reported EPS of 54 cents. The mean expectation of nineteen analysts for the quarter was for earnings of 40 cents per...Reuters
Tue, Apr 15
Stocks
Grocer Albertsons forecasts annual profit below estimates on rising costs
April 15 (Reuters) - Albertsons ACI.N forecast annual profit below estimates on Tuesday as the company offers selective discounts and invests in its loyalty program to drive sales while inflation pressures consumer spending, sending its shares down 3%. Retailers are tempering their annual expecta...Reuters
Tue, Apr 15
Cryptocurrencies
This Bitcoin Pullback Mirrors 2017’s Path To Parabolic Highs, Says Analyst
In a market update, prominent crypto commentator Rekt Capital examined Bitcoin’s latest dip through the lens of previous bull cycles, asserting that it closely resembles the 2017 pattern of multiple corrections en route to a parabolic top. Speaking in a video titled “Where’s The Bitcoin ‘Banana Zone...NewsBTC
Tue, Apr 15
Stocks
Nvidia and Tech Stock Investors Got Some Hopeful News Over the Weekend
In today's video, I discuss stocks including Nvidia (NASDAQ: NVDA) and weekend updates to the tariffs. To learn more, check out the short video, consider subscribing, and click the special offer link below.*Stock prices used were the after-market prices of April 11, 2025. The video was published on ...The Motley Fool
Tue, Apr 15
Other
Regional risk pools receive joint grant from Global Shield Solutions Platform
By Henry GaleApril 15 - (The Insurer) - The Global Shield Solutions Platform has agreed to provide a grant worth 4.7 million euros ($5.3 million) to the four regional catastrophe risk pools to fund shared initiatives, Africa's risk pool said in a LinkedIn post on Tuesday.The funding will be used...Reuters
Tue, Apr 15
Other
Arundo Re targets Indian subcontinent build-out with Chirimar hire
By Ryan HewlettApril 15 - (The Insurer) - Paris-based reinsurer Arundo Re, the recently rebranded CCR Re, has named Kshitij Chirimar as senior underwriter for the Indian subcontinent, a move designed expand the carrier’s footprint across the region.Chirimar brings over a decade of experience in the ...Reuters
Tue, Apr 15
Other
Win-Light Global Acquires An Additional 1,479,890 Connectm Shares, Boosting Buy-Out Group's Holdings To 24.5% Of Shares Outstanding
April 15 (Reuters) - ConnectM Technology Solutions Inc CNTM.O:WIN-LIGHT GLOBAL ACQUIRES AN ADDITIONAL 1,479,890 CONNECTM SHARES, BOOSTING BUY-OUT GROUP'S HOLDINGS TO 24.5% OF SHARES OUTSTANDINGCONNECTM TECHNOLOGY SOLUTIONS INC: BOARD OF DIRECTORS CONTINUES TO EVALUATE BUYOUT PROPOSALReuters
Tue, Apr 15
Other
Immunitybio Announces FDA Submissions Of Supplemental BLA For Nmibc Papillary Disease And For Expanded Access Of Anktiva®To Treat Lymphopenia
April 15 (Reuters) - Immunitybio Inc IBRX.O:IMMUNITYBIO ANNOUNCES FDA SUBMISSIONS OF SUPPLEMENTAL BLA FOR NMIBC PAPILLARY DISEASE AND FOR EXPANDED ACCESS OF ANKTIVA® TO TREAT LYMPHOPENIAIMMUNITYBIO ANNOUNCES FDA SUBMISSIONS OF SUPPLEMENTAL BLA FOR NMIBC PAPILLARY DISEASE AND FOR EXPANDED ACCESS OF A...Reuters
Tue, Apr 15
Other
Toragen- Positive Safety Data From Phase 1 Trial Of Tgn-S11, In Patients With Cancers Associated With Hpv
April 15 (Reuters) - TORAGEN- POSITIVE SAFETY DATA FROM PHASE 1 TRIAL OF TGN-S11, IN PATIENTS WITH CANCERS ASSOCIATED WITH HPVTORAGEN- EVIDENCE OF ACTIVITY IS IDENTIFIED FOR TGN-S11 AS A MONOTHERAPY AND IN COMBINATION WITH KEYTRUDATORAGEN- PHASE 1 TRIAL MET BOTH PRIMARY ENDPOINTS OF PROVING SAFETY A...Reuters
Tue, Apr 15
Other
FDA Clears Ceribell’S Clarity Algorithm For Pediatric Patients
April 15 (Reuters) - CeriBell Inc CBLL.O:FDA CLEARS CERIBELL’S CLARITY™ ALGORITHM FOR PEDIATRIC PATIENTS, MAKING CERIBELL THE FIRST AND ONLY FDA-CLEARED AI TECHNOLOGY FOR DETECTION OF ELECTROGRAPHIC SEIZURES IN PATIENTS AGES 1 YEAR AND OLDERReuters
Tue, Apr 15
